> ## Content Index
> Fetch the complete content index at: https://www.healthdatacon.io/llms.txt
> Use this file to discover other available public pages before exploring further.

# New tests emerge to augment imaging to speed concussion diagnoses
- URL: https://www.healthdatacon.io/articles/new-tests-emerge-to-augment-imaging-to-speed-concussion-diagnoses/
- Published: 2020-01-06T20:44:23.000Z
- Updated: 2026-11-10T10:37:00.000Z
- Description: Researchers are looking for ways other than imaging to diagnose concussions faster and more accurately, accelerating appropriate treatment in the process.
- Author: Fred Bazzoli
- Tags: Health IT

Researchers are looking for ways other than imaging to diagnose concussions faster and more accurately, accelerating appropriate treatment in the process.  
  
Concussions typically have widely varying symptoms and are typically among the most difficult forms of brain injury to diagnosis. In addition to examining a patient’s symptoms, clinicians often consider results from imaging scans, and neurological and cognitive tests, to identify this brain injury.  
  
  
However, these medical exams don’t always result in clear diagnoses, and false positives can pull resources away from concussion patients who might have severe cases.  
  
Researchers are trying to augment imaging and other exams for these brain injuries, according to recent articles in The Journal of Applied Laboratory Medicine, a publication of the American Association for Clinical Chemistry, that outline innovative clinical tests that laboratory medicine experts are developing to improve care for concussions. These new tests are intended to simplify the diagnostic process for concussions, which would enable quicker and more targeted interventions.  
  
One such test for concussion is a blood test that accurately identifies elderly concussion patients who do not have brain tissue damage. Researchers believe that the test could improve triage for elderly concussion patients, enabling clinicians to focus on cases that require urgent treatment, such as surgery.  
  
This test also was validated for use in younger adults, and when this earlier research came out, a popular misconception arose that the test could determine whether it was safe for an athlete to return to play after receiving blunt head trauma. A review in the Journal seeks to educate consumers on why a triage test can't be used for this purpose, and provides expert insight into the search for a blood test that could diagnose concussed athletes on the field.  
  
Concussion patients “represent a heterogeneous population, including older adults, young athletes and small children,” said review author Leslie M. Shaw, of the University of Pennsylvania’s Perelman School of Medicine in Philadelphia. “Diagnosing and treating these very different patients poses a diagnostic challenge for physicians, who must quickly decide whether to pursue imaging, whether to escalate care, as well as when to discharge and to advise 'return to play.' As a result, many biomarkers have been investigated, from decision-support scales to imaging to blood biomarkers."